The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to AbbVie
Related studies linked through entity extraction aliases.
Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan
- Status
- COMPLETED
- Phase
- N/A
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)
- Status
- COMPLETED
- Phase
- N/A
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
- Status
- COMPLETED
- Phase
- N/A
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection
- Status
- COMPLETED
- Phase
- PHASE3
[11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection
- Status
- COMPLETED
- Phase
- PHASE3
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1
Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Effectiveness of ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland
- Status
- COMPLETED
- Phase
- N/A
Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL)
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults
- Status
- COMPLETED
- Phase
- PHASE3
The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation
- Status
- COMPLETED
- Phase
- N/A
Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada
- Status
- COMPLETED
- Phase
- N/A
Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium
- Status
- COMPLETED
- Phase
- N/A
The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects
- Status
- COMPLETED
- Phase
- N/A
Post-Marketing Surveillance of Humira in Korean Pediatric Crohn's Disease (CD) Patients Under the "New-Drug Re-examination"
- Status
- COMPLETED
- Phase
- N/A
Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment
- Status
- TERMINATED
- Phase
- PHASE1